Could Positive Results on a COVID Anitbody Drug Be Just What the Markets Need?

Markets were under pressure Tuesday on renewed fears about the spread of the coronavirus, but could late-breaking news out of a Regeneron trial turn things around? Plus, after-hours earning action in shares of Micron, and will it be a happy holiday season for retailers? Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.